Announcement of Availability of the Fourteenth Report on Carcinogens, 76621 [2016-26604]
Download as PDF
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
submitted or for its use of that
information.
Background Information on
NICEATM: NICEATM conducts data
analyses, workshops, independent
validation studies, and other activities
to assess new, revised, and alternative
test methods and strategies. NICEATM
also provides support for the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM). The ICCVAM Authorization
Act of 2000 (42 U.S.C. 285l–3) provides
authority for ICCVAM and NICEATM in
the development of alternative test
methods. Information about NICEATM
and ICCVAM is found at https://
ntp.niehs.nih.gov/go/niceatm and
https://ntp.niehs.nih.gov/go/iccvam.
Dated: October 27, 2016.
Linda S. Birnbaum,
Director, National Institute of Environmental,
Health Sciences and National Toxicology
Program.
[FR Doc. 2016–26605 Filed 11–2–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement of Availability of the
Fourteenth Report on Carcinogens
The Department of Health and
Human Services released the 14th
Report on Carcinogens (RoC) to the
public on November 3, 2016. The report
is available on the RoC Web site at:
https://ntp.niehs.nih.gov/go/roc or from
the Office of the RoC (see ADDRESSES).
DATES: The 14th RoC is available to the
public on November 3, 2016.
ADDRESSES: Dr. Ruth Lunn, Director,
Office of the RoC, National Toxicology
Program (NTP), National Institute of
Environmental Health Sciences
(NIEHS), P.O. Box 12233, MD K2–14,
Research Triangle Park, NC 27709;
telephone: (919) 316–4637; FAX: (301)
480–2970; lunn@niehs.nih.gov.
FOR FURTHER INFORMATION CONTACT:
Questions or comments concerning the
14th RoC should be directed to Dr. Lunn
(see ADDRESSES).
SUPPLEMENTARY INFORMATION:
SUMMARY:
mstockstill on DSK3G9T082PROD with NOTICES
The RoC is a congressionally
mandated document that identifies and
discusses agents, substances, mixtures,
or exposure circumstances (collectively
referred to as ‘‘substances’’) that may
pose a hazard to human health because
of their carcinogenicity. Substances are
listed in the report as either known or
17:54 Nov 02, 2016
Jkt 241001
Dated: October 25, 2016.
Linda S. Birnbaum,
Director, National Institute of Environmental
Health Science and National Toxicology
Program.
[FR Doc. 2016–26604 Filed 11–2–16; 8:45 am]
Background Information on the RoC
VerDate Sep<11>2014
reasonably anticipated to be human
carcinogens. The listing of a substance
in the RoC indicates a potential hazard,
but does not establish the exposure
conditions that pose a cancer hazard to
individuals in their daily lives. For each
listed substance, the RoC provides
information from cancer studies that
support the listing, as well as
information about potential sources of
exposure and current federal regulations
to limit exposures. Each edition of the
RoC is cumulative, that is, it lists newly
reviewed substances in addition to
substances listed in the previous
edition. Information about the RoC is
available on the RoC Web site (https://
ntp.niehs.nih.gov/go/roc) or by
contacting Dr. Lunn (see ADDRESSES).
NTP prepares the RoC on behalf of the
Secretary of Health and Human
Services. For the 14th RoC, NTP
followed an established, multi-step
process with multiple opportunities for
public input, and used established
criteria to evaluate the scientific
evidence on each candidate substance
under review (https://ntp.niehs.nih.gov/
go/rocprocess).
New Listings in the 14th RoC: The
14th RoC contains 248 listings, some of
which consist of a class of structurally
related chemicals or agents. There are
six new listings and one revised listing
in this edition. The revised listing is for
trichloroethylene, which was previously
listed as reasonably anticipated to be a
human carcinogen and is now listed as
known to be a human carcinogen. Five
of the new listings are in the category of
known to be a human carcinogen:
Epstein Bar virus, Kaposi sarcomaassociated herpesvirus, human T-cell
lymphotropic virus type 1, human
immunodeficiency virus-type 1, and
Merkel cell polyomavirus. The new
listing in the category of reasonably
anticipated to be a human carcinogen is
for cobalt and cobalt compounds that
release cobalt ions in vivo.
BILLING CODE 4140–01–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
76621
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program Board of
Scientific Counselors; Announcement
of Meeting; Request for Comments
This notice announces the
next meeting of the National Toxicology
Program (NTP) Board of Scientific
Counselors (BSC). The BSC, a federally
chartered, external advisory group
composed of scientists from the public
and private sectors, will review and
provide advice on programmatic
activities. The meeting is open to the
public except for parts that are closed,
as indicated on the agenda. Registration
is requested for both attendance and
oral comment and required to access the
webcast. Information about the meeting
and registration are available at https://
ntp.niehs.nih.gov/go/165.
DATES: Meeting: December 14–15, 2016,
8:30 a.m. Eastern Standard Time (EST)
on both days and continues to
adjournment.
Written Public Comment
Submissions: Deadline is November 30,
2016.
Registration for Oral Comments:
Deadline is December 7, 2016.
Registration to Attend and/or View
Webcast: Deadline is December 15,
2016. Registration to view the meeting
via the webcast is required.
ADDRESSES: Meeting Location: Rodbell
Auditorium, Rall Building, National
Institute of Environmental Health
Sciences (NIEHS), 111 T.W. Alexander
Drive, Research Triangle Park, NC
27709.
Meeting Web page: The preliminary
agenda, registration, and other meeting
materials are at https://ntp.niehs.nih.gov/
go/165.
Webcast: The meeting will be webcast
on December 15; the URL will be
provided to those who register for
viewing.
SUMMARY:
Dr.
Lori White, Designated Federal Officer
for the BSC, Office of Liaison, Policy,
and Review, Division of NTP, NIEHS,
P.O. Box 12233, K2–03, Research
Triangle Park, NC 27709. Phone: 919–
541–9834, Fax: 301–480–3272, Email:
whiteld@niehs.nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2124, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Meeting and Registration: Parts of the
meeting are open to the public as
indicated on the agenda; in-person
attendance at NIEHS is limited only by
the space available. Parts of the meeting
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\03NON1.SGM
03NON1
Agencies
[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Page 76621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Announcement of Availability of the Fourteenth Report on
Carcinogens
SUMMARY: The Department of Health and Human Services released the 14th
Report on Carcinogens (RoC) to the public on November 3, 2016. The
report is available on the RoC Web site at: https://ntp.niehs.nih.gov/go/roc or from the Office of the RoC (see ADDRESSES).
DATES: The 14th RoC is available to the public on November 3, 2016.
ADDRESSES: Dr. Ruth Lunn, Director, Office of the RoC, National
Toxicology Program (NTP), National Institute of Environmental Health
Sciences (NIEHS), P.O. Box 12233, MD K2-14, Research Triangle Park, NC
27709; telephone: (919) 316-4637; FAX: (301) 480-2970;
lunn@niehs.nih.gov.
FOR FURTHER INFORMATION CONTACT: Questions or comments concerning the
14th RoC should be directed to Dr. Lunn (see ADDRESSES).
SUPPLEMENTARY INFORMATION:
Background Information on the RoC
The RoC is a congressionally mandated document that identifies and
discusses agents, substances, mixtures, or exposure circumstances
(collectively referred to as ``substances'') that may pose a hazard to
human health because of their carcinogenicity. Substances are listed in
the report as either known or reasonably anticipated to be human
carcinogens. The listing of a substance in the RoC indicates a
potential hazard, but does not establish the exposure conditions that
pose a cancer hazard to individuals in their daily lives. For each
listed substance, the RoC provides information from cancer studies that
support the listing, as well as information about potential sources of
exposure and current federal regulations to limit exposures. Each
edition of the RoC is cumulative, that is, it lists newly reviewed
substances in addition to substances listed in the previous edition.
Information about the RoC is available on the RoC Web site (https://ntp.niehs.nih.gov/go/roc) or by contacting Dr. Lunn (see ADDRESSES).
NTP prepares the RoC on behalf of the Secretary of Health and Human
Services. For the 14th RoC, NTP followed an established, multi-step
process with multiple opportunities for public input, and used
established criteria to evaluate the scientific evidence on each
candidate substance under review (https://ntp.niehs.nih.gov/go/rocprocess).
New Listings in the 14th RoC: The 14th RoC contains 248 listings,
some of which consist of a class of structurally related chemicals or
agents. There are six new listings and one revised listing in this
edition. The revised listing is for trichloroethylene, which was
previously listed as reasonably anticipated to be a human carcinogen
and is now listed as known to be a human carcinogen. Five of the new
listings are in the category of known to be a human carcinogen: Epstein
Bar virus, Kaposi sarcoma-associated herpesvirus, human T-cell
lymphotropic virus type 1, human immunodeficiency virus-type 1, and
Merkel cell polyomavirus. The new listing in the category of reasonably
anticipated to be a human carcinogen is for cobalt and cobalt compounds
that release cobalt ions in vivo.
Dated: October 25, 2016.
Linda S. Birnbaum,
Director, National Institute of Environmental Health Science and
National Toxicology Program.
[FR Doc. 2016-26604 Filed 11-2-16; 8:45 am]
BILLING CODE 4140-01-P